Patents by Inventor Elise Rioux

Elise Rioux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140296335
    Abstract: The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart conditions, cardiac arrhythmias, hypertensive crisis in an emergency room setting, hypertension before, during, or after surgery, no-reflow phenomenon following reperfusion, and diseases associated with decreased skeletal muscle blood flow. The invention also relates to pharmaceutical compositions formulated for use in such methods and to kits for such methods.
    Type: Application
    Filed: June 16, 2014
    Publication date: October 2, 2014
    Inventors: Martin P. MAGUIRE, Elise Rioux, Harry J. Leighton
  • Patent number: 8420638
    Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
    Type: Grant
    Filed: June 29, 2011
    Date of Patent: April 16, 2013
    Assignee: Gemin X Pharmaceuticals Canada Inc.
    Inventors: Giorgio Attardo, Jean-Francois Lavallee, Elise Rioux, Sasmita Tripathy, Terrance W. Deyle
  • Patent number: 8420693
    Abstract: The present invention relates to novel Dipyrrole Compounds, compositions comprising a Dipyrrole Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Dipyrrole Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus. The invention also provides screening assays for compounds that can be used in combination with Dipyrrole Compounds for the treatment of cancer or neoplastic disease, inhibition of cancer cell growth, or treatment of viral infections.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: April 16, 2013
    Assignee: Gemin X Pharmaceuticals Canada Inc.
    Inventors: Giorgio Attardo, Sasmita Triparthy, Elise Rioux, Gerson Gonzalez
  • Publication number: 20100190852
    Abstract: The present invention relates to the use of a pharmaceutically effective amount of an short-acting calcium channel blocking compound to treat ischemic heart conditions, cardiac arrhythmias, hypertensive crisis in an emergency room setting, hypertension before, during, or after surgery, no-reflow phenomenon following reperfusion, and diseases associated with decreased skeletal muscle blood flow. The invention also relates to pharmaceutical compositions formulated for use in such methods and to kits for such methods.
    Type: Application
    Filed: June 19, 2008
    Publication date: July 29, 2010
    Applicant: MILESTONE PHARMACEUTICALS INC.
    Inventors: Martin P. Maguire, Elise Rioux, Harry J. Leighton
  • Patent number: 7745435
    Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
    Type: Grant
    Filed: July 18, 2008
    Date of Patent: June 29, 2010
    Assignee: Gemix X Pharmaceuticals Canada Inc.
    Inventors: Giorgio Attardo, Jean-Francois Lavallee, Elise Rioux, Sasmita Tripathy, Terrence W. Doyle
  • Patent number: 7709477
    Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
    Type: Grant
    Filed: July 18, 2008
    Date of Patent: May 4, 2010
    Assignee: Gemin X Pharmaceuticals Canada Inc.
    Inventors: Giorgio Attardo, Jean-Francois Lavallee, Elise Rioux, Sasmita Tripathy, Terrence W. Doyle
  • Publication number: 20080318903
    Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
    Type: Application
    Filed: July 18, 2008
    Publication date: December 25, 2008
    Applicant: Gemin X Pharmaceuticals Canada Inc.
    Inventors: Giorgio Attardo, Kenza Dairi, Jean-Francois Lavallee, Elise Rioux, Sasmita Tripathy, Terrence W. Doyle, Xavuer Billot
  • Publication number: 20080318902
    Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
    Type: Application
    Filed: July 18, 2008
    Publication date: December 25, 2008
    Applicant: Gemin X Pharmaceuticals Canada Inc.
    Inventors: Giorgio Attardo, Jean-Francois Lavallee, Elise Rioux, Sasmita Tripathy, Terrence W. Doyle
  • Publication number: 20080280896
    Abstract: The present invention relates to novel Dipyrrole Compounds, compositions comprising a Dipyrrole Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Dipyrrole Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus. The invention also provides screening assays for compounds that can be used in combination with Dipyrrole Compounds for the treatment of cancer or neoplastic disease, inhibition of cancer cell growth, or treatment of viral infections.
    Type: Application
    Filed: December 22, 2005
    Publication date: November 13, 2008
    Applicant: GEMIN X BIOTECHNOLOGIES INC.
    Inventors: Giorgio Attardo, Sasmita Triparthy, Elise Rioux, Gerson Gonzalez
  • Patent number: 7425553
    Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
    Type: Grant
    Filed: May 28, 2004
    Date of Patent: September 16, 2008
    Assignee: Gemin X Pharmaceuticals Canada inc.
    Inventors: Giorgio Attardo, Jean-Francois Lavallee, Elise Rioux, Terrence W. Doyle
  • Patent number: 7230139
    Abstract: The present invention relates to Diterpenoid Compounds, compositions comprising an effective amount of a Diterpenoid Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering an effective amount of a Diterpenoid Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, or for inducing apoptosis in a cancer or neoplastic cell. The compounds, compositions, and methods of the invention are further useful for treating or preventing a fungal infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a fungus.
    Type: Grant
    Filed: June 10, 2004
    Date of Patent: June 12, 2007
    Assignee: Gemin X Biotechnologies
    Inventors: Jean-Francois Lavallee, Terrence W. Doyle, Elise Rioux, Laurent Belec, Daniel Rabouin, Xavier Billot, Samuel Fortin
  • Publication number: 20050032802
    Abstract: The present invention relates to Diterpenoid Compounds, compositions comprising an effective amount of a Diterpenoid Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering an effective amount of a Diterpenoid Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, or for inducing apoptosis in a cancer or neoplastic cell. The compounds, compositions, and methods of the invention are further useful for treating or preventing a fungal infection. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a fungus.
    Type: Application
    Filed: June 10, 2004
    Publication date: February 10, 2005
    Inventors: Jean-Francois Lavallee, Terrence Doyle, Elise Rioux, Laurent Belec, Daniel Rabouin, Xavier Billot
  • Publication number: 20050014802
    Abstract: The present invention relates to novel Triheterocyclic Compounds, compositions comprising a Triheterocyclic Compound, and methods useful for treating or preventing cancer or a neoplastic disorder comprising administering a Triheterocyclic Compound. The compounds, compositions, and methods of the invention are also useful for inhibiting the growth of a cancer cell or neoplastic cell, treating or preventing a viral infection, or inhibiting the replication and/or infectivity of a virus.
    Type: Application
    Filed: May 28, 2004
    Publication date: January 20, 2005
    Inventors: Giorgio Attardo, Kenza Dairi, Jean-Francois Lavallee, Elise Rioux, Sasmita Tripathy, Terrence Doyle, Xavier Billot